Abstract
Dietary (n−3) fatty acids mediate physiological processes in at least two different ways. The activities of the liver enzymes that metabolize fatty acids and synthesize triglycerides are modified by the type of fat that is fed. These changes include an elevated rate of fatty acid oxidation along with a reduced rate of fatty acid biosynthesis1,2. The mechanism of action of (n−3) acids at the enzyme level is still a matter of conjecture. Clarke and Armstrong3 have recently reported that rats fed a fish oil diet had reduced levels of mRNA for fatty acid synthetase. These findings suggest that (n−3) fatty acids, or one of their metabolites, regulate enzyme synthesis rather than enzyme activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P.J. Nestel, S. Wong and D.L. Topping, Dietary long chain polyenoic acids: 1. Suppression of triglyceride formation in rat liver: 2. Attenuation in man of the effects of dietary cholesterol on lipoprotein cholesterol, in: “Health Effects of Polyunsaturated Fatty Acids in Seafoods”, A.P. Simopoulos, R.R. Kifer and R.E. Martin, eds., Academic Press, Orlando, Florida, pp. 211–246 (1986).
P.J. Nestel, D. Topping, J. Marsh, S. Wong, H. Barrett, P. Roach and B. Kambouris, Effects of polyenoic fatty acids (n-3) on lipid and lipoprotein metabolism, in: “Polyunsaturated Fatty Acids and Eicosanoids”, W.E.M. Lands, ed., American Oil Chemists’ Society, Champaign, Illinois, pp. 94–102 (1987).
S.D. Clarke and M.K. Armstrong, Suppression of rat liver fatty acid synthetase mRNA level by dietary fish oil, Federation Proceedings Abstracts, Abstract 3235: 1988.
J.T. Bernert and H. Sprecher, Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids, Biochim. Biophys. Acta 398: 354 (1975).
B.O. Christophersen, T-A. Hagve and J. Norseth, Studies on the regulation of arachidonic acid synthesis in isolated liver cells, Biochim. Biophys. Acta 712: 305 (1982).
T-A. Hagve and B.O. Christophersen, Linolenic acid desaturation and chain elongation and rapid turnover of phospholipid (n-3) fatty acids in isolated rat liver cells, Biochim. Biophys. Acta 753: 339 (1983).
M.A. Thiede, J. Ozols and P. Strittmatter, Construction and sequence of cDNA for rat liver stearoyl-coenzyme A desaturase, J. Biol. Chem. 261: 13230 (1986).
M.A. Thiede and P. Strittmatter, The induction and characterization of rat liver stearyl-CoA desaturase mRNA, J. Biol. Chem. 260: 14459 (1985).
T.W. Weiner and H. Sprecher, Arachidonic acid, 5,8,11eicosatreinoic acid and 5,8,11,14,17-eicosapentaenoic acid, dietary manipulation of the levels of these acids in rat liver and platelet phospholipids and their incorporation into human platelet phospholipid, Biochim. Biophys. Acta 792: 293 (1984).
W-H. Kunau and F. Bartnik, Studies on the partial degradation of polyunsaturated fatty acids in rat-liver mitochondria, Eur. J. Biochem. 48: 311 (1974).
C. von Schacky and P.C. Weber, Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acid in humans, J. Clin. Invest. 76: 2446 (1985).
S. Fischer, A. Vischer, V. Preac-Mursil and P.C. Weber, Dietary docosahexaenoic acid is ketroconverted in man to eicosapentaenoic acid, which can be quickly transformed to prostaglandin I3, Prostaglandins 34: 367 (1987).
J.T. Bernert and H. Sprecher, An analysis of partial reactions in the overall chain elongation of saturated and unsaturated fatty acids in rat liver microsomes, J. Biol. Chem. 252: 6736 (1977).
M.N. Nagai, L. Cook, R. Prasad and D. Cinti, Do rat hepatic microsomes contain multiple NADPH-supported fatty acid chain elongation pathways or a single pathway? Biochem. Biophys. Res. Commun. 140: 74 (1986).
R. Jeffcoat and A.J. James, The regulation of desaturation and elongation of fatty acids in mammals, in: Fatty Acid Metabolism and its Regulation“, Vol. 7, New Comprehensive Biochemistry, S. Numa, ed., Elsevier, New York, pp. 85–112 (1984).
J.D. Lefkowith, V. Flippo, H. Sprecher and P. Needleman, Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency, J. Biol. Chem. 260: 15736 (1985).
P. Falardeau, M. Hamberg, and B. Samuelsson, Metabolism of 8,11,14-eicosatrienoic acid in platelets, Biochim. Biophys. Acta 491: 193 (1976).
M. Hamberg and B. Samuelsson, Prostaglandin endoperoxides: Novel transformation of arachidonic acid in human platelets, Proc. Natl. Acad. Sci. USA 71: 3400 (1974).
M. VanRollins, L. Horrocks and H. Sprecher, Metabolism of 7,10,13,16-docosatetraenoic acid to dihomothromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy acids by human platelets, Biochim. Biophys. Acta 833: 272 (1985).
M. Milks and H. Sprecher, Metabolism of 4,7,10,13,16docosapentaenoic acid by platelet cyclooxygenase and lipoxygenase, Biochim. Biophys. Acta 835: 29 (1985).
Sprecher, H., M. VanRollins, F. Sun, A. Wyche, and P. Needleman, Dihomo-prostaglandin and thromboxanes: A novel prostaglandin family from adrenic acid that may specifically be synthesized in the kidney, J. Biol. Chem. 257: 3912 (1982).
W.B. Campbell, J.R. Falck, J.R. Okita, A.R. Johnson and K.S. Callahan, Synthesis of dihomoprostaglandin from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells, Biochim. Biophys. Acta 837: 67 (1985).
M. Hamberg, Transformation of 5,8,11,14,17eicosapentaenoic acid in human platelets, Biochim. Biophys. Acta 618: 389 (1980).
E.H. Oliw, H. Sprecher and M. Hamberg, Isolation of two novel prostaglandins in human seminal fluid, J. Biol. Chem. 261: 2675 (1986).
M. Hamberg, w-Oxygenation of 6,9,12-octadecatrienoic acid in human platelets, Biochem. Biophys. Res. Commun. 117: 593 (1983).
M.M. Careaga and H. Sprecher, Metabolism of 8,11,14,17eicosatetraenoic acid by human platelet lipoxygenase and cyclooxygenase, Biochim. Biophys. Acta 920: 94 (1987).
M.I. Aveldano and H. Sprecher, Synthesis of hydroxy fatty acids from 4,7,10,13,16,19-[1–14C]docosahexaenoic acid, J. Biol. Chem. 258: 9339 (1983).
M.M. Careaga and H. Sprecher, Synthesis of two hydroxy fatty acids from 7,10,13,16,19-docosapentaenoic acid by human platlets, J. Biol. Chem. 259: 14413 (1984).
Y-K. Wong, P. Westlund, M. Hamberg, E. Granstrom, PH-W. Chao and B. Samuelsson, 15-Lipoxygenase in human platelets, J. Biol. Chem. 260: 9162 (1985).
R.W. Bryant, J.M. Bailey, T. Schewe and S.M. Rappoport, Positional specificity of a reticulocyte lipoxygenase. Conversion of arachidonic acid to 15S-hydroperoxyeicosatetraenoic acid, J. Biol. Chem. 257: 6050 (1982).
F.H. Chilton, J.M. Ellis, S.C. Olson and R.L. Wykle, 1–0-Alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonulcear leukocytes, J. Biol. Chem. 259: 12014 (1984).
F.H. Chilton and R.C. Murphy. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil, J. Biol. Chem. 261: 7771 (1986).
C.L. Swendsen, F.H. Chilton, J.T. 0/Flaherty, J.R. Surles, C. Piantadosi, M. Waite and R.L. Wykle. Human neutrophils incorporate arachidonic acid and saturated fatty acids into separate molecular species of phospholipids, Biochim. Biophys. Acta919: 79 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sprecher, H. (1989). (N-3) and (N-6) Fatty Acid Metabolism. In: Galli, C., Simopoulos, A.P. (eds) Dietary ω3 and ω6 Fatty Acids. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2043-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2043-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2045-7
Online ISBN: 978-1-4757-2043-3
eBook Packages: Springer Book Archive